Evidence map›Paper›PMID 29896195›Full record

ArticleFrontiers in immunology2018

Cholesterol Crystal-Mediated Inflammation Is Driven by Plasma Membrane Destabilization.

Fei Shu, Jiahuan Chen, Xiaojie Ma, Yunzhou Fan, Li Yu, Wencheng Zheng, Matthias W Amrein, Tie Xia, Yan Shi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Cholesterol-containing lipid crystals can directly stiffen the rat steatotic liver before fibrosis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Review
  5. Anti-Atherogenic Mechanisms and Therapies.Current atherosclerosis reports · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Fei ShuPeking University-Tsinghua University-National Institute of Biological Sciences Joint Graduate Program, School of Life Sciences, Peking University, Beijing, China.
Jiahuan ChenDepartment of Basic Medical Sciences, Center for Life Sciences, Institute for Immunology, Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, China.
Xiaojie MaDepartment of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Yunzhou FanDepartment of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Li YuDepartment of Basic Medical Sciences, Center for Life Sciences, Institute for Immunology, Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, China.
Wencheng ZhengDepartment of Basic Medical Sciences, Center for Life Sciences, Institute for Immunology, Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, China.
Matthias W AmreinDepartment of Cell Biology, Snyder Institute, University of Calgary, Calgary, AB, Canada.
Tie XiaDepartment of Basic Medical Sciences, Center for Life Sciences, Institute for Immunology, Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, China.
Yan ShiDepartment of Basic Medical Sciences, Center for Life Sciences, Institute for Immunology, Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, China.
Tsinghua University · CNCenter for Life Sciences · CNPeking University · CNUniversity of Calgary · CA

Funding

Adjuvants' mechanismsR01AI098995 · NIAID · UNIVERSITY OF CALGARY · PI SHI, YAN · 2012 to 2016
$1.0M
CIHR MOP-119295NIAID NIH HHS R01 AI098995
6 · The paper itself

Abstract

Atherosclerosis is driven by an inflammatory milieu in the walls of artery vessels. Initiated early in life, it progresses to plaque formation and form cell accumulation. A culprit in this cascade is the deposition of cholesterol crystals (CC). The involvement of smaller crystals in the early stage of atherosclerotic changes may be critical to the long-term pathological development. How these small crystals initiate the pro-inflammatory events is under study. We report here an unexpected mechanism that microscopic CC interact with cellular membrane in a phagocytosis-independent manner. The binding of these crystals extracts cholesterol from the cell surface. This process causes a sudden catastrophic rupture of plasma membrane and necrosis of the bound cells independent of any known cell death-inducing pathways, releasing inflammatory agents associated with the necrotic cell death. Our results, therefore, reveal a biophysical aspect of CC in potentially mediating the inflammatory progress in atherosclerosis.

Indexed as

AnimalsAtherosclerosisCell MembraneCholesterolMiceMice, KnockoutNecrosisCholesterolcell deathcholesterol crystalsinflammationmembrane rupturesignal free

Identifiers

PMID29896195
PMCPMC5986904
OpenAlexW2802447487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.